Scadenza: 6 May 2021
Topic:
Project results are expected to contribute to all the following expected outcomes:
- European researchers and public health actors fighting the spread of infectious diseases, e.g. COVID-19 and emerging infectious diseases are able to store, share, access, analyse, process and cite research and clinical data and other research digital objects across disciplines and national borders and to collaborate with global partners;
- federation of viral and human infectious disease data from national and international centres enables pan-European and global sharing and combination of research and clinical data, thereby catalysing and accelerating research advances to combat the COVID-19 pandemic and prepare for future outbreaks;
- development of digital tools and data analytics for pandemic and outbreak preparedness, including tracking genomic variations of SARS-CoV-2, linking genomic and clinical data to support timely identification of variants of concern, and subsequent rapid characterisation of such strains to inform public health action;
- linking of FAIR data and metadata on SARS-CoV-2 and COVID-19, on other related viruses and diseases, and on socio-economic consequences, across research fields, from omics, clinical, and epidemiological research, to Social Sciences and Humanities accelerate infectious disease research, surveillance and outbreak investigation;
- contribute to the Horizon Europe European Open Science Cloud (EOSC) Partnership and to the development of the European Health Data Space (EHDS).
This action responds to the need to enable researchers, health care professionals and society at large to share, access, analyse, link and process research data and other research digital objects across disciplines and national borders in response to the COVID-19 pandemic
Programma:
Horizon Europe Framework Programme (HORIZON)
Type of action:
HORIZON-RIA HORIZON Research and Innovation Actions
Ente finanziatore:
EU
Budget complessivo:
12.000.000 €
Who can participate:
Any legal entity, regardless of its place of establishment, including legal entities from nonassociated third countries or international organisations (including international European research organisations) is eligible to participate
Partnership: Mandatory
Status:
Closed
Quota finanziabile:
100%
Topic:
Project results are expected to contribute to all the following expected outcomes:
- European researchers and public health actors fighting the spread of infectious diseases, e.g. COVID-19 and emerging infectious diseases are able to store, share, access, analyse, process and cite research and clinical data and other research digital objects across disciplines and national borders and to collaborate with global partners;
- federation of viral and human infectious disease data from national and international centres enables pan-European and global sharing and combination of research and clinical data, thereby catalysing and accelerating research advances to combat the COVID-19 pandemic and prepare for future outbreaks;
- development of digital tools and data analytics for pandemic and outbreak preparedness, including tracking genomic variations of SARS-CoV-2, linking genomic and clinical data to support timely identification of variants of concern, and subsequent rapid characterisation of such strains to inform public health action;
- linking of FAIR data and metadata on SARS-CoV-2 and COVID-19, on other related viruses and diseases, and on socio-economic consequences, across research fields, from omics, clinical, and epidemiological research, to Social Sciences and Humanities accelerate infectious disease research, surveillance and outbreak investigation;
- contribute to the Horizon Europe European Open Science Cloud (EOSC) Partnership and to the development of the European Health Data Space (EHDS).
This action responds to the need to enable researchers, health care professionals and society at large to share, access, analyse, link and process research data and other research digital objects across disciplines and national borders in response to the COVID-19 pandemic
Who can participate:
Any legal entity, regardless of its place of establishment, including legal entities from nonassociated third countries or international organisations (including international European research organisations) is eligible to participate
Programme:
Horizon Europe Framework Programme (HORIZON)
Type of action:
HORIZON-RIA HORIZON Research and Innovation Actions
Consortium: Required
Status: Open
Total budget:
12.000.000 €
Funding rate:
100%
